Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transferrin Receptor-Mediated Uptake at the Blood–Brain Barrier Is Not Impaired by Alzheimer’s Disease Neuropathology
Philippe Bourassa, Waël Alata, Cyntia Tremblay, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 2, pp. 583-594
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Targeting the transferrin receptor for brain drug delivery
Kasper Bendix Johnsen, Annette Burkhart, Louiza Bohn Thomsen, et al.
Progress in Neurobiology (2019) Vol. 181, pp. 101665-101665
Open Access | Times Cited: 264
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
Mazen M. El‐Hammadi, José L. Arias
Nanomaterials (2022) Vol. 12, Iss. 3, pp. 354-354
Open Access | Times Cited: 80
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
Sudip Mukherjee, Vijay Sagar Madamsetty, Dwaipayan Bhattacharya, et al.
Advanced Functional Materials (2020) Vol. 30, Iss. 35
Closed Access | Times Cited: 117
Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy
Aneesha Achar, Rosemary Myers, Chaitali Ghosh
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1834-1834
Open Access | Times Cited: 91
Recent advances and perspectives of aggregation-induced emission as an emerging platform for detection and bioimaging
Imran Mahmood Khan, Sobia Niazi, Muhammad Kashif Iqbal Khan, et al.
TrAC Trends in Analytical Chemistry (2019) Vol. 119, pp. 115637-115637
Closed Access | Times Cited: 79
Transcellular brain drug delivery: A review on recent advancements
Mehrdad Azarmi, Hadi Maleki, Nader Nikkam, et al.
International Journal of Pharmaceutics (2020) Vol. 586, pp. 119582-119582
Closed Access | Times Cited: 77
Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases
Keelan Jagaran, Moganavelli Singh
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9082-9082
Open Access | Times Cited: 72
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Geetika Nehra, Bjoern Bauer, Anika M. S. Hartz
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108119-108119
Open Access | Times Cited: 70
Evolving new-age strategies to transport therapeutics across the blood-brain-barrier
Manisha Choudhari, Siddhanth Hejmady, Ranendra Narayan Saha, et al.
International Journal of Pharmaceutics (2021) Vol. 599, pp. 120351-120351
Closed Access | Times Cited: 61
Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
Maj Schneider Thomsen, Kasper Bendix Johnsen, Krzysztof Kucharz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2237-2237
Open Access | Times Cited: 50
Lipid Nanoparticles: Promising Treatment Approach for Parkinson’s Disease
Keelan Jagaran, Moganavelli Singh
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9361-9361
Open Access | Times Cited: 44
Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
Livia La Barbera, Emanuele Mauri, Marcello D’Amelio, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 43
Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target
João André Sousa, Catarina Bernardes, Sara Bernardo-Castro, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 29
Nose‐to‐brain delivery of nanotherapeutics: Transport mechanisms and applications
Kunyao Xu, Suqin Duan, Wenjing Wang, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 13
Targeting insulin‐like growth factor‐1 receptor (IGF1R) for brain delivery of biologics
Waël Alata, Álvaro Yogi, Eric Brunette, et al.
The FASEB Journal (2022) Vol. 36, Iss. 3
Open Access | Times Cited: 37
Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases
Debashish Paramanick, Veena Devi Singh, Vijay Kumar Singh
Journal of Controlled Release (2022) Vol. 351, pp. 638-655
Closed Access | Times Cited: 30
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
Louise Reveret, Manon Leclerc, Vincent Émond, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer’s Disease Is Associated with Activation of HIF-1 Signaling Pathway
Sabrina Petralla, Liudmila Saveleva, Katja M. Kanninen, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6383-6394
Open Access | Times Cited: 6
Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature
Manon Leclerc, Cyntia Tremblay, Philippe Bourassa, et al.
Journal of Cerebral Blood Flow & Metabolism (2024) Vol. 44, Iss. 8, pp. 1417-1432
Open Access | Times Cited: 6
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer’s disease
Ilaria Arduino, Rosa Maria Iacobazzi, Chiara Riganti, et al.
International Journal of Pharmaceutics (2020) Vol. 591, pp. 120011-120011
Open Access | Times Cited: 41
Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applications
Ruijie Huang, Xingyu Zhou, Guiyuan Chen, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 14, Iss. 4
Closed Access | Times Cited: 23
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
Rebecca Faresjö, Dag Sehlin, Stina Syvänen
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and superb treatment of orthotopic glioblastoma
Qianyi Fan, Yuanyuan Liu, Guanhong Cui, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 1139-1149
Closed Access | Times Cited: 35
Brain mural cell loss in the parietal cortex in Alzheimer’s disease correlates with cognitive decline and TDP‐43 pathology
Philippe Bourassa, Cyntia Tremblay, Julie A. Schneider, et al.
Neuropathology and Applied Neurobiology (2020) Vol. 46, Iss. 5, pp. 458-477
Open Access | Times Cited: 33
Can Natural Products Exert Neuroprotection without Crossing the Blood–Brain Barrier?
Manon Leclerc, Stéphanie Dudonné, Frédéric Calon
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3356-3356
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top